Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Status:
Completed
Trial end date:
2011-01-18
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of letrozole in treating women who have
recurrent or metastatic endometrial cancer.